Panmure Gordon is delighted to have acted as sole Bookrunner, Broker and Nominated Adviser to Arecor Therapeutics on their recent placing to raise £6.0 million and acquisition of Tetris Pharma, a commercial stage speciality pharmaceutical company. The proceeds of the Placing will be used to support the acquisition…
Read more
We are delighted to have acted as corporate adviser, sole broker and sole bookrunner with the £10m IPO and introduction to AQSE of Equipmake Holdings PLC. Read the full press release below. Equipmake Holdings PLC (“Equipmake” or the “Company“) Admission to trading on AQSE and…
Read more
We are delighted to announce that our Healthcare Research Analyst, Dr. Julie Simmonds, has been crowned ‘Analyst of the Year 2022’ by the Small Cap Network Awards. Thank you to all the judges who voted. Find out more about the Small Cap Network Awards here: https://smallcapnetwork.co.uk/…
Read more
We are pleased to announced that Panmure Gordon has this morning been appointed as Financial Adviser, Nominated Adviser and sole Broker to GetBusy Plc. GetBusy is listed on AIM with a £29m market cap. GetBusy is a Cambridge-based SaaS business, which is primarily engaged in the development…
Read more
We are delighted to announce that Panmure Gordon has been appointed as Nominated Adviser and Sole Broker to Smoove PLC. Smoove plc is the customer focused technology and services business aiming to revolutionise home moving and ownership. Congratulations to all those involved, especially our Panmure Gordon colleagues:…
Read more
10th May 2022 – We are pleased to announce that Panmure Gordon has this morning been appointed joint broker to AIM listed AMTE Power plc (AMTE.L) alongside WH Ireland (NOMAD). Having listed in March 2021, raising £13.7m, AMTE is involved in developing and manufacturing lithium-ion and sodium-ion battery…
Read more
We are delighted to announce that Panmure Gordon acted as Financial Adviser, Nominated Adviser, Broker and Bookrunner to Ebiquity plc on its acquisitions of MediaPath Network and MMi, and the associated equity Placing of £15.0m. The Placing has received significant support from existing shareholders and new blue chip institutional…
Read more
We are pleased to announce that Panmure Gordon has this morning been appointed joint broker to AssetCo (ASTO LN). AssetCo is a £113m market cap AIM company primarily involved in acquiring, managing, and operating asset and wealth management activities and interests, together with other related services. AssetCo has…
Read more
We are delighted to announce that Panmure Gordon acted as financial adviser, broker and bookrunner to HydrogenOne Capital Growth plc on its oversubscribed £21.5 million fundraise. HydrogenOne Capital LLP are investment advisers to HydrogenOne Capital Growth plc, an investment trust established to provide investors with exposure to opportunities…
Read more
We are delighted to announce that we have been appointed as NOMAD and joint broker to Cambridge Cognition Plc. Cambridge Cognition Plc is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. It provides gold standard clinically validated software for…
Read more
London, UK, 1st February 2022: Kooth Work has been selected by Panmure Gordon, a UK Investment Bank to help deliver proactive and preventative mental health and wellbeing support to all its employees and their families. Forming one of the core foundations of Panmure Gordon’s employee…
Read more
UK investment bank commits to strong regional presence Panmure Gordon has opened a new office in Leeds to provide investment banking services to high-growth potential companies and institutional clients across the North of England. The UK investment bank has appointed managing director Simon J French as head of…
Read more